|
||||||||||||||||
|
||||||||||||||||
HUM-MOLGEN -> Events | Search | Write an announcement | ||||||||||||||||
Meetings and Conferences by date |
||||||||||||||||
October, 01 2023 |
your calendar for events in
genetics, biotechnology and medicine |
|||||||||||||||
October 2023 | 2023 -10-02 Pharma Development and Business: lentiviral vectors remain the go-to choice for the efficient delivery of large therapeutic genes to patient cells. in addition to ex vivo indica 4th Generation Lentiviral Vectors: An Improved Gene Delivery System |
Xtalks, online | ||||||||||||||
02-03 October 2023 Biotechnology: The events provide a unique networking platform which consists of vital discussion topics in: Formulation & Drug Delivery and Inhalation & Respiratory Drug Delivery. Formulation & Delivery US 2023 |
Oxford Global Conferences, Hilton San Diego Mission Valley | |||||||||||||||
2023 -10-03 Pharma Development and Business: patient samples are collected, and now it’s essential to make sure they get where they’re supposed to go. a lab may have routine studies or a fa Clinical Sample Management: Expecting the Unexpected – How to Avoid Losing a Sample |
Xtalks, online | |||||||||||||||
2023 -10-03 Pharma Development and Business: advances in biomarker testing are revolutionizing strategies for diagnosing and managing neurological disorders and shifting the current treatme Precision Medicine and Alzheimer’s Disease: Overcoming Biomarker Testing Barriers for Alzheimer’s Disease Patients |
Xtalks, online | |||||||||||||||
2023 -10-03 Pharma Development and Business: sleep is essential for overall health and emotional well-being. better sleep health leads to a better quality of life, lending to a wide range o Optimizing Sleep During Perimenopause and Beyond |
Xtalks, online | |||||||||||||||
2023 -10-04 Pharma Development and Business: the quantitative polymerase chain reaction (qpcr) has transformed the world of molecular biology methodology by enabling fast, high-throughput d Best Practices and Benefits of qPCR Automation |
Xtalks, online | |||||||||||||||
2023 -10-04 Pharma Development and Business: join the featured speakers for an engaging webinar that delves into cutting-edge advancements in clinical trial workflow management. in this inf Harnessing AI for Clinical Trial Workflow Management |
Xtalks, online | |||||||||||||||
2023 -10-05 Pharma Development and Business: cell and gene therapy (cagt) is a rapidly evolving field that holds enormous promise for ground-breaking treatments therapies in various disease Updates in Cell and Gene Therapy with a Focus on Kidney Disease and Operational Considerations |
Xtalks, online | |||||||||||||||
2023 -10-05 Pharma Development and Business: over the past few years, the progression from pen and paper to remote and digitized data capture and the shift from an exclusive focus on clinic Are Sensors and Wearables Really the Future of Data Capture in Clinical Trials? |
Xtalks, online | |||||||||||||||
2023 -10-06 Pharma Development and Business: bloodstream infections can be detrimental to all patient populations, however, in certain patient populations, such as cancer patients, there is Experiences with a Rapid Multiplex NAT System for Bloodstream Infections at a Tertiary Cancer Center |
Xtalks, online | |||||||||||||||
2023 -10-06 Pharma Development and Business: in the dynamic landscape of clinical trials, the efficient enrollment of the right participants stands as a pivotal goal. this webinar delves in Patient-Centric Clinical Trials: Strategies for Accelerated Enrollment, Data Insights and Trial Success |
Xtalks, online | |||||||||||||||
2023 -10-10 Pharma Development and Business: the landscape of drug development is constantly evolving, presenting pharmaceutical companies with unique challenges that demand innovative solu Drug Product Development: Challenges and Strategies for High-Potent and Low-Dosed Products |
Xtalks, online | |||||||||||||||
2023 -10-10 Pharma Development and Business: how to strategically plan and implement tactics to drive diversity in clinical researchmany patients groups are underrepresented in clinical Taking a proactive and holistic approach to diversity assessment and planning |
Xtalks, online | |||||||||||||||
10 - 12 October 2023 Cancer Research: 5th Goodbye Flat Biology Conference (EACR) EACR Goodbye Flat Biology: Next Generation Cancer Models |
European Association for Cancer Research (EACR), Berlin | |||||||||||||||
14-11-2023 Others: Discuss the latest innovations in novel targets & target validation in immuno-oncology Targets & Cell Types in Immuno-Oncology Europe 2023 |
Oxford Global, Berlin, Germany | |||||||||||||||
12th-13th October 2023 Biochemistry / Immunology: Discuss the latest strategies to harness the immune system for the development of innovative therapeutics Immuno US 2023 |
Oxford Global Conferences, Hilton San Diego Bayfront, 1 Park Blvd, CA 92101 | |||||||||||||||
12-13 October Biotechnology: Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine Biomarkers US 2023 |
Oxford Global Conferences, Hilton San Diego Bayfront | |||||||||||||||
2023-10-12 to 2023-10-14 Medical Research (others): 20TH CPD DIABETES ASIA CONFERENCE 2023 (DAC 2023) Diabetes Asia Conference 2023 |
National Diabetes Institute (NADI), Royale Chulan Kuala Lumpur, Malaysia | |||||||||||||||
2023 -10-12 Pharma Development and Business: the use of medical imaging biomarkers to better understand the efficacy of cancer drugs, aided by the power of ai.oncology clinical trials w Advances in oncological imaging: Tumour growth rate modelling and radiomics |
Xtalks, online | |||||||||||||||
2023 -10-13 Pharma Development and Business: regulated digital polymerase chain reaction (dpcr), quantitative polymerase chain reaction (qpcr) and reverse transcriptase quantitative polymer dPCR, qPCR and RT-qPCR: Advantages and Challenges in Pre-clinical and Clinical Development |
Xtalks, online | |||||||||||||||
2023 -10-16 Pharma Development and Business: as the somatic cell and gene therapy platforms continue to advance, so do the us food and drug administration (fda) and international council fo Cell and Gene Therapy Clinical Trials’ Regulatory Strategies and Safety Considerations |
Xtalks, online | |||||||||||||||
2023 -10-16 Pharma Development and Business: eeg analysis (electroencephalography) is becoming a promising translatable biomarker for predicting the likelihood that novel therapies and comp EEG Analysis and Animal Behavior in CNS Drug Development |
Xtalks, online | |||||||||||||||
2023 -10-16 Pharma Development and Business: cell-free systems aim to capture some properties and functions of living cells without using living cells. by building cell-free systems such as Cell-Free Riboswitches: Engineering and Applications |
Xtalks, online | |||||||||||||||
2023 -10-18 Pharma Development and Business: for clinical trials in mood disorders, two of the most widely leveraged and long-standing assessments of depression severity are the montgomery– Improve Data Reliability from MADRS and HAM-D Assessments in Clinical Trials: Scientific and Operational Recommendations |
Xtalks, online | |||||||||||||||
2023 -10-20 Pharma Development and Business: the explosion of healthcare data has created an organisational imperative to devise a robust and flexible framework to integrate this data while Beyond the Token: Why Your Healthcare Data and Integration Strategy Matters |
Xtalks, online | |||||||||||||||
2023 -10-26 Pharma Development and Business: the shift from manual data entry of medical records to the automatic acquisition of data from multiple real-world sources is no longer a ‘nice t A Step-by-Step Approach to eSource in Clinical Trials |
Xtalks, online | |||||||||||||||
November 2023 | 01-02 November 2023 Others: Join and network with over 250 industry leaders at Discovery US 2023, where we will address the latest advancements in target identification, validation and HIT optimisation. Discovery US 2023 |
Oxford Global, Cambridge, MA, USA | ||||||||||||||
1st November - 2nd November Medical Research (others): Join and network with over 250 industry leaders at Discovery US 2023, where we will address the latest advancements in target identification, validation and HIT optimisation. The 2-day programme addr Discovery US 2023 |
Oxford Global, Le Méridien Boston Cambridge 20 Sidney Street Cambridge Massachusetts, 02139 | |||||||||||||||
09-10 November 2023 Biochemistry / Immunology: Join leaders, experts and researchers at the most scientifically engaging event in London delivering breakthrough research, technologies and therapeutic applications across Next Generation Sequencing, NextGen Omics 2023 |
ExceL London (ICC Capital Suite), 1 Western Gateway, London E16 1XL | |||||||||||||||
14-11-2023 - 15-11-2023 Biochemistry / Immunology: Accelerate timelines and reduce risk in drug development through optimised biomarker analysis Biomarker Analysis Europe 2023 |
Oxford Global, Hotel Palace Berlin | |||||||||||||||
14-15 November 2023 Biochemistry / Immunology: Advance key molecular characterizations for the emergence of more targeted and precise treatments in oncology Precision Oncology Europe 2023 |
Hotel Palace Berlin, Budapester Str. 45, 10787 Berlin, Germany | |||||||||||||||
14-16 November 2023 Cancer Research: EACR Cellular Bases for Patient Response to Cancer Therapies EACR Cellular Bases for Patient Response to Cancer Therapies |
European Association for Cancer Research (EACR), Lyon | |||||||||||||||
15 – 17 November 2023 Genetics: 12th International Conference Epigenomics of Common Diseases 2023 |
Wellcome Connecting Science, Wellcome Genome Campus, Hinxton, CB10 1RQ, UK + virtual | |||||||||||||||
December 2023 | 05-06 December 2023 Cancer Research: EACR-AstraZeneca Cancer Epigenetics EACR-AstraZeneca Cancer Epigenetics |
European Association for Cancer Research (EACR) and AstraZeneca, Virtual event (worldwide access) | ||||||||||||||
February 2024 | 27-29 February 2024 Cancer Research: The EACR and AACR are proud to announce the 2024 edition of their joint Basic and Translational Research Conference, organised in conjunction with the IACR. EACR-AACR-IACR Basic & Translational Research Conference 2024: How to Bring Basic Science Discoveries to the Clinic |
European Association for Cancer Research (EACR) & American Association for Cancer Research (AACR), with support from the Irish Association for Cancer Research (IACR), Dublin, Ireland | ||||||||||||||
29/02/2024 Others: Europe’s flagship event for Biomarker Research Returns: the must-attend forum to engage with the latest trends transforming biomarker and translational research Biomarkers 2024 |
Oxford Global, Novotel London West, London, UK | |||||||||||||||
March 2024 | 19-21 March 2024 Cancer Research: Tickets now available! The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities |
The European Association for Cancer Research (EACR) , Bergamo, Italy | ||||||||||||||
April 2024 | 30 April - 02 May 2024 Cancer Research: Registrations now open - submit your abstracts today EACR Cancer Multiomics & Computational Biology |
The European Association for Cancer Research (EACR) , Rehovot, Israel | ||||||||||||||
September 2024 | 2024-09-21 Biotechnology: SECOND Announcement, XIIX iNTERNATIONAL ETHNOMEDICINE SYMPOSIO Contributions to Ethnomedicine Biotech Readings |
FRIENDS THE UNIVERSITY FOR PEACE FOUNDATION, Palazzo dei Congressi Roma EUR, Italy Viale Shakespeare14, Roma | ||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |